InspireMD is headquartered in Tel Aviv, Israel
In 2005.
InspireMD is a Delaware Corporation.
InspireMD’s common shares and warrants trade on NASDAQ under the ticker symbols NSPR and NSPR.Z, respectively.
InspireMD’s quarterly financials are released approximately 45 days following the end of the preceding quarter and approximately 90 days following the end of the fiscal year.
InspireMD’s fiscal year ends December 31st.
No, InspireMD does not currently have a direct stock purchase plan.
InspireMD does not currently pay dividends.
Kesselman & Kesselman, Certified Public Accountants, a member of PricewaterhouseCoopers International Limited.
45779A101.
Each year we welcome all of our shareholders to the InspireMD Annual Meeting of Stockholders. Notice of the meeting will be set forth in the annual proxy statement.
Justeene Blankenship
Action Stock Transfer Corp.
2469 E. Fort Union Blvd, Ste 214
Salt Lake City, UT 84121
Office: (801) 274-1088
Mobile: (801) 599-3678
Fax: (801) 274-1099
justblank2000@yahoo.com
www.actionstocktransfer.com
Craig Shore
Chief Financial Officer
InspireMD, Inc
Phone: 1-888-776-6804
Email: craigs@inspiremd.com
Or you can reach our investor relations department by emailing investors@inspiremd.com.